Skip to main content
Clinical Trials/ACTRN12620000855921
ACTRN12620000855921
Suspended
Phase 4

Investigating the efficacy of early vs. late primaquine treatment for children with uncomplicated malaria due to infection with either Plasmodium vivax or Plasmodium falciparum

The University of Western Australia0 sites220 target enrollmentAugust 27, 2020

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
The University of Western Australia
Enrollment
220
Status
Suspended
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 27, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • i) Children aged 0\.5 to 12 years
  • ii) Axillary temperature \>37\.5 degrees Celcius (or self\-reported fever during previous 24 hours)
  • iii) Positive for malaria by on\-site microscopy, or rapid diagnostic test, or polymerase chain reaction
  • iv) Have not received a study intervention in the previous 4 weeks
  • v) They have no significant co\-morbidity
  • vi) they can attend follow\-up assessments over the full duration of the study.

Exclusion Criteria

  • i) Clinical signs or symptoms consistent with severe malaria
  • ii) History of allergy to artemether\-lumefantrine or primaquine
  • iii) A proven history of G6PD deficiency
  • iv) Severe malnutrition
  • v) Haemoglobin \<50 g/

Outcomes

Primary Outcomes

Not specified

Similar Trials